DOCSLIB.ORG

Determination of Methemoglobin in Hemoglobin Submicron Particles Using NMR Relaxometry

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

International Journal of Molecular Sciences Article Determination of Methemoglobin in Hemoglobin Submicron Particles Using NMR Relaxometry Waraporn Kaewprayoon 1,2, Nittiya Suwannasom 1,3 , Chiraphat Kloypan 1,4 , Axel Steffen 1 , Yu Xiong 1 , Eyk Schellenberger 5, Axel Pruß 1, Radostina Georgieva 1,6 and Hans Bäumler 1,* 1 Charité-Universitätsmedizin Berlin, Institute of Transfusion Medicine, 10117 Berlin, Germany; [email protected] (W.K.); [email protected] (N.S.); [email protected] (C.K.); Axel.steff[email protected] (A.S.); [email protected] (Y.X.); [email protected] (A.P.); [email protected] (R.G.) 2 Department of Pharmacy, Payap University, Chiang Mai 50000, Thailand 3 Division of Biochemistry and Nutrition, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand 4 Division of Clinical Immunology and Transfusion Sciences, School of Allied Health Sciences, University of Phayao, Phayao 56000, Thailand 5 Charité-Universitätsmedizin Berlin, Institute of Radiology and Children Radiology, 10117 Berlin, Germany; [email protected] 6 Department of Medical Physics, Biophysics and Radiology, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria * Correspondence: [email protected]; Tel.: +49-(30)-45052-5131 Received: 30 October 2020; Accepted: 23 November 2020; Published: 26 November 2020 Abstract: Methemoglobin (MetHb) is a hemoglobin (Hb) derivative with the heme iron in ferric state (Fe3+), unable to deliver oxygen. Quantification of methemoglobin is a very important diagnostic parameter in hypoxia. Recently, novel hemoglobin microparticles (Hb-MP) with a narrow size distribution around 700 nm, consisting of cross-linked Hb were proposed as artificial oxygen carriers. The cross-linking of Hb by glutaraldehyde (GA) generates a certain amount of MetHb. Due to the strong light scattering, quantitative determination of MetHb in Hb-MP suspensions by common 1 spectrophotometry is not possible. Here, we demonstrate that H2O NMR relaxometry is a perfect tool for direct measurement of total Hb and MetHb concentrations in Hb-MP samples. The longitudinal relaxation rate 1/T1 shows a linear increase with increasing MetHb concentration, whereas the transverse relaxation rate 1/T2 linearly increases with the total Hb concentration. In both linear regressions the determination coefficient (R2) is higher than 0.99. The method does not require time-consuming pretreatment or digestion of the particles and is not impaired by light scattering. Therefore, it can be established as the method of choice for the quality control of Hb-MP and similar hemoglobin-based oxygen carriers in the future. 1 Keywords: methemoglobin; hemoglobin microparticles (Hb-MP); H2O NMR-relaxometry; hemoglobin-based oxygen carriers 1. Introduction Hemoglobin (Hb), the main component of red blood cells (RBC), is an iron-containing oxygen-transporting metalloprotein. It contains four heme groups each incorporating an iron atom in 2+ the ferrous state (Fe ), which can reversibly bind molecular oxygen (O2), resulting in two states of Hb—the oxygenated Hb (OxyHb) and the deoxygenated Hb (DeoxyHb). In this way, RBC are loaded with O2 in the lung (OxyHb) and O2 is delivered to the organs/tissue (DeoxyHb) [1,2]. In contrast Int. J. Mol. Sci. 2020, 21, 8978; doi:10.3390/ijms21238978 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2020, 21, 8978 2 of 13 to these two Hb-states, Hb derivatives are altered forms of hemoglobin, which are formed by the combination of different iron ligands in the heme or by the oxidation state of the iron. After oxidation, the iron in the heme group changes to the ferric state (Fe3+) and Hb becomes methemoglobin (MetHb). MetHb cannot bind or carry oxygen molecules since the sixth coordination position of iron is bound either to a water molecule or a hydroxyl group [3,4]. Furthermore, the presence of MetHb increases the affinity of the remaining Hb or heme groups to oxygen, which makes the oxygen release in the tissues more difficult [4,5]. Normally one to two percent of a person’s Hb is MetHb [5]. A higher percentage, can be of genetic origin or caused by exposure to various chemicals [3,6]. Depending on the level of MetHb in the blood, it can cause health problems known as methemoglobinemia. Therefore, the MetHb concentration in blood is a very important diagnostic parameter in cases of hypoxia. One of common methods of hemoglobin analysis in clinical laboratories are based on the so called multiple wavelength spectrophotometry (CO-oximetry) [7–10], which exploits the differences in the absorption spectra of OxyHb, DeoxyHb, and MetHb. Before measurement, Hb is released from the RBCs by hemolysis to avoid the light scattering by the cells. Recently, novel hemoglobin microparticles (Hb-MP) have been developed and proposed as artificial oxygen carriers. The fabrication procedure was published under the abbreviation CCD-technique (Co-precipitation-Crosslinking-Dissolution) [11–13] that reflects the three main preparation steps: co-precipitation of Hb with MnCO3, crosslinking of Hb and dissolution of the MnCO3. The resulting particles consist of cross-linked Hb and show a narrow size distribution around 700 nm. The particles were investigated spectrophotometrically to demonstrate their oxygenation and deoxygenation [11,14]. However, Hb-MP cannot be lysed like RBC and a quantitative determination of OxyHb, DeoxyHb, and MetHb by multiple-wavelength spectrophotometry is not possible due to the strong light scattering of the Hb-MP suspensions. It is known, that the cross-linking of Hb by glutaraldehyde (GA) causes a certain amount of MetHb to arise [15]. Therefore, a quantitative measurement of the MetHb content of the Hb-MP is very important in view of their potential application as an artificial blood substitute and alternatives to spectrophotometric measurements are needed. In previous studies, the oxygen carrying capacity of the Hb-MP was used for the indirect determination of dyshemoglobin or nonfunctional hemoglobin. The oxygen released after oxidation of the Hb by cyanide was directly measured and related to the amount of functional Hb in the Hb-MP [12,16]. The difference between total Hb and functional Hb equals nonfunctional hemoglobin. However, this method does not allow a direct measurement of MetHb and presupposes 100% oxygenation of the Hb in the Hb-MP. 1 The water proton nuclear magnetic resonance ( H2O NMR) relaxometry could be a suitable method that can be used for quantification of the MetHb concentration directly by measuring the oxidative state of iron in the Hb-MP.The different oxidation state of the iron in MetHb means that MetHb has a different electronic configuration and, therefore, different paramagnetic properties compared to 1 that of Hb [17]. This difference can be detected using NMR spectroscopy by measuring the H2O NMR longitudinal relaxation time (T1) and the transverse relaxation time (T2) or the corresponding relaxation rates (1/T1 and 1/T2). Previous studies on methemoglobin concentrations in blood samples have shown comparable values obtained by NMR and multiples-wavelength spectrophotometry [18,19] but the NMR method is not influenced by light scattering and does not require lysis of RBC. Additionally, NMR provides information on the molecular environment and therefore it would allow to investigate the influence of the GA crosslinking on the molecular structure of Hb in the Hb-MP. 1 The aim of this study was to demonstrate that the H2O NMR relaxation rates can be used to determine the total Hb as well as MetHb content of Hb-MP, because multiple wavelength 1 spectrophotometry cannot be applied. Therefore, the H2O NMR relaxation times of Hb in Hb-solutions and in vital RBC were measured at various MetHb concentrations to investigate the influence of different surroundings on their relaxation properties. The influence of the GA crosslinking on the 1 H2O NMR relaxation rates was investigated using GA cross-linked RBC and GA HSA-MP. Finally, Int. J. Mol. Sci. 2020, 21, 8978 3 of 13 1 Hb-MP suspensions with different MetHb contents were prepared and the H2O NMR relaxation rates wereInt. J. measured.Mol. Sci. 2020, 21, x FOR PEER REVIEW 3 of 14 2.2. ResultsResults andand DiscussionDiscussion 2.1.2.1. NMRNMR ofof HumanHuman HbHb/MetHb/MetHb Solutions Solutions and and RBCs RBCs/MetHb-RBC/MetHb-RBC Suspensions Suspensions FigureFigure1 1shows shows thethe relaxationrelaxation rates 1/T 1 /T1 and1 and 1/T 12/ Tof2 Hbof Hbsolutions solutions and andsuspensions suspensions of intact of intact RBCs RBCsdepending depending on the on MetHb the MetHb concentration. concentration. It can It be can seen be seenthat thatboth, both, the thelongitudinal longitudinal as well as well as the as thetransverse transverse relaxation relaxation accelerate accelerate with with increasing increasing MetHb MetHb concentration. concentration. The The increase ofof 11/T/T11 withwith increasingincreasing MetHb MetHb concentration concentration is is roughly roughly equivalent equivalent in in Hb Hb solutions solutions and and suspensions suspensions of of intact intact RBCs RBCs (Figure(Figure1 A),1A), whereas whereas 1 1/T/T2 2increases increases much much faster faster with with the the MetHb MetHb concentration concentration in in RBC RBC suspensions suspensions (Figure(Figure1 B).1B). This This is is in in agreement agreement with with the th resultse results obtained obtained by by other other groups groups [20 [20–23].–23]. Figure 1. Relaxation rates 1/T1 (A) and 1/T2 (B) of Hb solutions and of RBC suspension as a function of Figure 1. Relaxation rates 1/T1 (A) and 1/T2 (B) of Hb solutions and of RBC suspension as a function the MetHb concentration (measured at proton frequency 40 MHz and temperature 37 C). The values of the MetHb concentration (measured at proton frequency 40 MHz and temperature◦ 37 °C). The represent means and standard deviations of N = 6 samples. The slopes of 1/T1 for Hb solutions (0.0226) values represent means and standard deviations of N = 6 samples.
Recommended publications
  • Hemoglobin Variants: Biochemical Properties and Clinical Correlates

    Hemoglobin Variants: Biochemical Properties and Clinical Correlates

    Downloaded from http://perspectivesinmedicine.cshlp.org/ on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Hemoglobin Variants: Biochemical Properties and Clinical Correlates Christopher S. Thom1,2, Claire F. Dickson3, David A. Gell3, and Mitchell J. Weiss2 1Cell and Molecular Biology Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 2Hematology Department, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 3Menzies Research Institute, University of Tasmania, Hobart, Australia Correspondence: [email protected] Diseases affecting hemoglobin synthesis and function are extremely common worldwide. More than 1000 naturally occurring human hemoglobin variants with single amino acid substitutions throughout the molecule have been discovered, mainly through their clinical and/or laboratory manifestations. These variants alter hemoglobin structure and biochem- ical properties with physiological effects ranging from insignificant to severe. Studies of these mutations in patients and in the laboratory have produced a wealth of information on he- moglobin biochemistry and biology with significant implications for hematology practice. More generally, landmark studies of hemoglobin performed over the past 60 years have established important paradigms for the disciplines of structural biology, genetics, biochem- istry, and medicine. Here we review the major classes of hemoglobin variants, emphasizing general concepts and illustrative examples. lobin gene mutations affecting hemoglobin stitutions, antitermination mutations, and al- G(Hb), the major blood oxygen (O2) carrier, tered posttranslational processing (Table 1). are common, affecting an estimated 7% of the Naturally occurring Hb mutations cause a world’s population (Weatherall and Clegg 2001; range of biochemical abnormalities, some of Kohne 2011). These mutations are broadly sub- which produce clinically significant symptoms.
  • Hemoglobinopathies: Clinical & Hematologic Features And

    Hemoglobinopathies: Clinical & Hematologic Features And

    Hemoglobinopathies: Clinical & Hematologic Features and Molecular Basis Abdullah Kutlar, MD Professor of Medicine Director, Sickle Cell Center Georgia Health Sciences University Types of Normal Human Hemoglobins ADULT FETAL Hb A ( 2 2) 96-98% 15-20% Hb A2 ( 2 2) 2.5-3.5% undetectable Hb F ( 2 2) < 1.0% 80-85% Embryonic Hbs: Hb Gower-1 ( 2 2) Hb Gower-2 ( 2 2) Hb Portland-1( 2 2) Hemoglobinopathies . Qualitative – Hb Variants (missense mutations) Hb S, C, E, others . Quantitative – Thalassemias Decrease or absence of production of one or more globin chains Functional Properties of Hemoglobin Variants . Increased O2 affinity . Decreased O2 affinity . Unstable variants . Methemoglobinemia Clinical Outcomes of Substitutions at Particular Sites on the Hb Molecule . On the surface: Sickle Hb . Near the Heme Pocket: Hemolytic anemia (Heinz bodies) Methemoglobinemia (cyanosis) . Interchain contacts: 1 1 contact: unstable Hbs 1 2 contact: High O2 affinity: erythrocytosis Low O2 affinity: anemia Clinically Significant Hb Variants . Altered physical/chemical properties: Hb S (deoxyhemoglobin S polymerization): sickle syndromes Hb C (crystallization): hemolytic anemia; microcytosis . Unstable Hb Variants: Congenital Heinz body hemolytic anemia (N=141) . Variants with altered Oxygen affinity High affinity variants: erythrocytosis (N=93) Low affinity variants: anemia, cyanosis (N=65) . M-Hemoglobins Methemoglobinemia, cyanosis (N=9) . Variants causing a thalassemic phenotype (N=51) -thalassemia Hb Lepore ( ) fusion Aberrant RNA processing (Hb E, Hb Knossos, Hb Malay) Hyperunstable globins (Hb Geneva, Hb Westdale, etc.) -thalassemia Chain termination mutants (Hb Constant Spring) Hyperunstable variants (Hb Quong Sze) Modified and updated from Bunn & Forget: Hemoglobin: Molecular, Genetic, and Clinical Aspects. WB Saunders, 1986.
  • 18,8 Quaternary Structure of Proteins

    18,8 Quaternary Structure of Proteins

    570 CHAPTERt8 Amino Acids,Peptides, and Proteins 18,8Quaternary structure of proteins AIMS: Todefine the termssubunit dnd quaternarystructure. Io describethe quoternorystructure of hemoglobin.To distinguishomong oxyhemoglobin,deoxyhemoglobin, ond methemoglobin. Someproteins consist of more than one pollpeptide chain. Theseindiuid- ual chains are calledsubunits of the protein. Proteins composedof subunits In some proteins, polypeptide are said to haue quaternary structure. Many proteins have structures that chains aggregateto form contain subunits. Proteins consistingof dimers (two subunits), tetramers quaternary structures. (four subunits), and hexamers (six subunits) are fairly common. The pro- teins that comprise the individual subunits may be identical, or they may be different. Like the secondary and tertiary structures, the quaternary structure of a protein is determined by its primary structure. The pollpep- tide chains of subunits are held in place by the same forces that determine tertiary structure-hydrogen bonds, salt bridges, and sometimes disulfide bridges-except the forces are betweenthe polypeptide chains of the sub- units instead of within them. Hydrophobic aliphatic and aromatic side chains of subunits can aggregateto exclude water. Hemoglobin-the globular oxygen-transport protein of blood-is an example of a protein that has a quaternary structure. Max Perutz, also of the Medical ResearchCouncil laboratories,determined the structure of horse blood hemoglobin in 1959.Hemoglobin is a larger molecule than myoglo- bin. The hemoglobin molecule has a molar mass of 64,500.It contains about 5000 individual atoms, excluding hydrogens, in 574 amino acid residues. The quaternary structure of hemoglobin consistsof four peptide sub- units. TWo of the subunits are identical and are called the alpha subunits.
  • The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: a Review

    The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: a Review

    Journal of Clinical Medicine Review The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review Felix Scholkmann 1,2,*, Tanja Restin 2, Marco Ferrari 3 and Valentina Quaresima 3 1 Biomedical Optics Research Laboratory, Department of Neonatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland 2 Newborn Research Zurich, Department of Neonatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland; [email protected] 3 Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; [email protected] (M.F.); [email protected] (V.Q.) * Correspondence: [email protected]; Tel.: +41-4-4255-9326 Abstract: Following the outbreak of a novel coronavirus (SARS-CoV-2) associated with pneumonia in China (Corona Virus Disease 2019, COVID-19) at the end of 2019, the world is currently facing a global pandemic of infections with SARS-CoV-2 and cases of COVID-19. Since severely ill patients often show elevated methemoglobin (MetHb) and carboxyhemoglobin (COHb) concentrations in their blood as a marker of disease severity, we aimed to summarize the currently available published study results (case reports and cross-sectional studies) on MetHb and COHb concentrations in the blood of COVID-19 patients. To this end, a systematic literature research was performed. For the case of MetHb, seven publications were identified (five case reports and two cross-sectional studies), and for the case of COHb, three studies were found (two cross-sectional studies and one case report). The findings reported in the publications show that an increase in MetHb and COHb can happen in COVID-19 patients, especially in critically ill ones, and that MetHb and COHb can increase to dangerously high levels during the course of the disease in some patients.
  • Phd Thesis Tjaard Pijning

    Phd Thesis Tjaard Pijning

    University of Groningen Divergent or just different Rozeboom, Henriette IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2014 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Rozeboom, H. (2014). Divergent or just different: Structural studies on six different enzymes. [S.n.]. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 29-09-2021 Divergent or just different Structural studies on six different enzymes Henriëtte Rozeboom Printed by Ipskamp Drukkers, Enschede The research presented in this thesis was carried out in the Protein Crystallography group at the Groningen Biomolecular Sciences and Biotechnology Institute.
  • Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies

    Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies

    Journal of Clinical Medicine Article Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies Coralea Stephanou, Stella Tamana , Anna Minaidou, Panayiota Papasavva, , , Marina Kleanthous * y and Petros Kountouris * y Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia 2371, Cyprus; [email protected] (C.S.); [email protected] (S.T.); [email protected] (A.M.); [email protected] (P.P.) * Correspondence: [email protected] (M.K.); [email protected] (P.K.); Tel.:+357-2239-2652 (M.K.); +357-2239-2623 (P.K.) Equal contribution; Joint last authorship. y Received: 20 September 2019; Accepted: 5 November 2019; Published: 9 November 2019 Abstract: Haemoglobinopathies are common monogenic disorders with diverse clinical manifestations, partly attributed to the influence of modifier genes. Recent years have seen enormous growth in the amount of genetic data, instigating the need for ranking methods to identify candidate genes with strong modifying effects. Here, we present the first evidence-based gene ranking metric (IthaScore) for haemoglobinopathy-specific phenotypes by utilising curated data in the IthaGenes database. IthaScore successfully reflects current knowledge for well-established disease modifiers, while it can be dynamically updated with emerging evidence. Protein–protein interaction (PPI) network analysis and functional enrichment analysis were employed to identify new potential disease modifiers and to evaluate the biological profiles of selected phenotypes. The most relevant gene ontology (GO) and pathway gene annotations for (a) haemoglobin (Hb) F levels/Hb F response to hydroxyurea included urea cycle, arginine metabolism and vascular endothelial growth factor receptor (VEGFR) signalling, (b) response to iron chelators included xenobiotic metabolism and glucuronidation, and (c) stroke included cytokine signalling and inflammatory reactions.
  • Concentration of NADH-Cytochrome B5 Reductase in Erythrocytes of Normal and Methemoglobinemic Individuals Measured with a Quantitative Radioimmunoblotting Assay

    Concentration of NADH-Cytochrome B5 Reductase in Erythrocytes of Normal and Methemoglobinemic Individuals Measured with a Quantitative Radioimmunoblotting Assay

    Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay. N Borgese, … , G Pietrini, S Gaetani J Clin Invest. 1987;80(5):1296-1302. https://doi.org/10.1172/JCI113205. Research Article The activity of NADH-cytochrome b5 reductase (NADH-methemoglobin reductase) is generally reduced in red cells of patients with recessive hereditary methemoglobinemia. To determine whether this lower activity is due to reduced concentration of an enzyme with normal catalytic properties or to reduced activity of an enzyme present at normal concentration, we measured erythrocyte reductase concentrations with a quantitative radioimmunoblotting method, using affinity-purified polyclonal antibodies against rat liver microsomal reductase as probe. In five patients with the "mild" form of recessive hereditary methemoglobinemia, in which the activity of erythrocyte reductase was 4-13% of controls, concentrations of the enzyme, measured as antigen, were also reduced to 7-20% of the control values. The concentration of membrane-bound reductase antigen, measured in the ghost fraction, was similarly reduced. Thus, in these patients, the reductase deficit is caused mainly by a reduction in NADH-cytochrome b5 reductase concentration, although altered catalytic properties of the enzyme may also contribute to the reduced enzyme activity. Find the latest version: https://jci.me/113205/pdf Concentration of NADH-Cytochrome b5 Reductase in Erythrocytes of Normal and Methemoglobinemic
  • Pathological Conditions Involving Extracellular Hemoglobin

    Pathological Conditions Involving Extracellular Hemoglobin

    Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for alpha(1)-Microglobulin Gram, Magnus; Allhorn, Maria; Bülow, Leif; Hansson, Stefan; Ley, David; Olsson, Martin L; Schmidtchen, Artur; Åkerström, Bo Published in: Antioxidants & Redox Signaling DOI: 10.1089/ars.2011.4282 2012 Link to publication Citation for published version (APA): Gram, M., Allhorn, M., Bülow, L., Hansson, S., Ley, D., Olsson, M. L., Schmidtchen, A., & Åkerström, B. (2012). Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for alpha(1)-Microglobulin. Antioxidants & Redox Signaling, 17(5), 813-846. https://doi.org/10.1089/ars.2011.4282 Total number of authors: 8 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
  • The First Korean Family with Hemoglobin-M Milwaukee-2 Leading to Hereditary Methemoglobinemia

    The First Korean Family with Hemoglobin-M Milwaukee-2 Leading to Hereditary Methemoglobinemia

    Case Report Yonsei Med J 2020 Dec;61(12):1064-1067 https://doi.org/10.3349/ymj.2020.61.12.1064 pISSN: 0513-5796 · eISSN: 1976-2437 The First Korean Family with Hemoglobin-M Milwaukee-2 Leading to Hereditary Methemoglobinemia Dae Sung Kim1, Hee Jo Baek1,2, Bo Ram Kim1, Bo Ae Yoon1,2, Jun Hyung Lee3, and Hoon Kook1,2 1Department of Pediatrics, Chonnam National University Hwasun Hospital, Hwasun; 2Department of Pediatrics, Chonnam National University Medical School, Gwangju; 3Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Korea. Hemoglobin M (HbM) is a group of abnormal hemoglobin variants that form methemoglobin, which leads to cyanosis and he- molytic anemia. HbM-Milwaukee-2 is a rare variant caused by the point mutation CAC>TAC on codon 93 of the hemoglobin sub- unit beta (HBB) gene, resulting in the replacement of histidine by tyrosine. We here report the first Korean family with HbM-Mil- waukee-2, whose diagnosis was confirmed by gene sequencing. A high index of suspicion for this rare Hb variant is necessary in a patient presenting with cyanosis since childhood, along with methemoglobinemia and a family history of cyanosis. Key Words: ‌Hemoglobin M-Milwaukee-2, methemoglobinemia, cyanosis, congenital hemolytic anemia INTRODUCTION tion pathway.6 Methemoglobinemia occurs when metHb lev- els exceed 1.5% in blood.7 Hereditary methemoglobinemia is Hemoglobinopathy refers to abnormalities in hemoglobin often caused by methemoglobin reductase enzyme deficiency,
  • Evidence of the Existence of a High Spin Low Spin Equilibrium in Liver Microsomal Cytochrome P450, and Its Role in the Enzymatic Mechanism* H

    Evidence of the Existence of a High Spin Low Spin Equilibrium in Liver Microsomal Cytochrome P450, and Its Role in the Enzymatic Mechanism* H

    CROATICA CHEMICA ACTA CCACAA 49 (2) 251-261 (1977) YU ISSN 0011-1643 CCA-996 577.15.087.8 :541.651 Conference Paper Evidence of the Existence of a High Spin Low Spin Equilibrium in Liver Microsomal Cytochrome P450, and its Role in the Enzymatic Mechanism* H. Rei:n, 0. Ristau, J. Friedrich, G.-R. Jiinig, and K. RuckpauL Department of Biocatalysis, C'entral Institute of Molecular Biology, Academy of Sciences of the GDR 1115 Berlin, GDR Received November 8, 1976 In rabbit liver microsomal cytochrome P450 a high spin (S = = 5/2) low spin (S = 1/2) equilibrium has been proved to exist by recording temperature difference spectra in the Soret and in the visible region of the absorption spectrum of solubilized cytochrome P450. In the presence of type II substrates the predominantly low spin state of cytochrome P450 is maintained, only a very small shift to lower spin is observed. Ligands of the heme iron, such as cyanide and imidazole, pr9duce a pure low spin state and therefore in the presence of these ligands no temperature difference spectra can be obtained. In the presence of type I substrate, however, the spin equilibrium is shifted to the high spin state. The extent of this shift (1) depends on specific properties of the substrate and (2) it is generally relatively small, up to about 80/o in the case of substrates investigated so far. INTRODUCTION The first step in the reaction cycle of cytochrome P450 is the binding of the substrate to the enzyme. The binding is connected with changes in the absorption spectrum especially in the Soret region from which the binding constant can be evaluated1• Moreover, in the case of the so far best known cytochrome P450 from Pseudomonas putida it has been established that at substrate binding the low spin state of the heme iron is changed into the high spin state2• In the presence of camphor, a specific substrate, bacterial cytochrome P450 exhibits in the EPR spectrum g values of 8, 4, and 1.8, typical of high spin ferric heme iron in a strong distorted rhombic field.
  • Role of Methemoglobin and Carboxyhemoglobin Levels in Predicting COVID-19 Prognosis: an Observational Study

    Role of Methemoglobin and Carboxyhemoglobin Levels in Predicting COVID-19 Prognosis: an Observational Study

    RESEARCH ARTICLE Role of methemoglobin and carboxyhemoglobin levels in predicting COVID-19 prognosis: an observational study Begüm Öktem1, Fatih Üzer2, *, Fatma Mutlu Kukul Güven1, İdris Kırhan3, Mehmet Topal4 1 Department of Emergency Medicine, Kastamonu State Hospital, Kastamonu Turkey 2 Department of Pulmonology, Kastamonu State Hospital, Kastamonu, Turkey 3 Department of Internal Medicine, Harran University Faculty of Medicine, Şanlıurfa, Turkey 4 Department of Biostatistics, Kastamonu University Faculty of Medicine, Kastamonu, Turkey *Correspondence to: Fatih Üzer, MD, [email protected]. orcid: 0000-0001-9318-0458 (Fatih Üzer) Abstract World Health Organization has declared coronavirus disease-19 (COVID-19) as a pandemic. Although there are studies about this novel virus, our knowledge is still limited. There is limited information about its diagnosis, treatment and prognosis. We aimed to investigate the effect of methemoglobin and carboxyhemoglobin levels on the prognosis of COVID-19. In this observational study, patients who were diagnosed with COVID-19 during March 1–April 31, 2020 in a secondary-level state hospital in Turkey were included in the study. COVID-19 diagnosis was confirmed with reverse transcription polymerase chain reaction method, with nasal, oral or sputum specimens. During the period this study was performed, 3075 patients were tested for COVID-19 and 573 of them were hospitalized. Among the hospitalised patients, 23.2% (133) of them had a positive polymerase chain reaction result for COVID-19. A total of 125 patients, 66 (52.8%) males and 59 (47.2%) females, with an average age of 50.2 ± 19.8 years, were included in the study. The most common findings in chest radiogram were ground-glass areas and consolidations, while one-third of the patients had a normal chest radiogram.
  • The Formation of Methemoglobin and Sulfhemoglobin During Sulfanilamide Therapy

    The Formation of Methemoglobin and Sulfhemoglobin During Sulfanilamide Therapy

    THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY J. S. Harris, H. O. Michel J Clin Invest. 1939;18(5):507-519. https://doi.org/10.1172/JCI101064. Research Article Find the latest version: https://jci.me/101064/pdf THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY By J. S. HARRIS AND H. 0. MICHEL (From the Departments of Pediatrics and Biochemistry, Duke University School of Medicine, Durham) (Received for publication April 8, 1939) Cyanosis almost invariably follows the admin- during the administration of sulfanilamide. Wen- istration of therapeutic amounts of sulfanilamide del (10) found spectroscopic evidence of met- (1). This cyanosis is associated with and is due hemoglobin in every blood sample containing over to a change in the color of the blood. The dark- 4 mgm. per cent sulfanilamide. Evelyn and Mal- ening of the blood is present only in the red cells loy (11) have found that all patients receiving and therefore must be ascribed to one of two sulfanilamide show methemoglobinemia, although causes, a change in the hemoglobin itself or a the intensity is usually very slight. Finally Hart- staining of the red cells with some product formed mann, Perley, and Barnett (12) found cyanosis during the metabolism of sulfanilamide. It is the associated with methemoglobinemia in almost ev- purpose of this paper to assay quantitatively the ery patient receiving over 0.1 gram sulfanilamide effect of sulfanilamide upon the first of these fac- per kilogram of body weight per day. They be- tors-that is, upon the formation of abnormal lieved that the intensity of the methemoglobinemia heme pigments.